Showing results (1-10 of 64) with videos related to
Sort By:
Pageof 7
ACS Medicinal Chemistry Letters|June 22, 2019
Modifications at Arg and Ile Give Neurotensin(8-13) Derivatives with High Stability and Retained NTS1 Receptor AffinityLisa Schindler, Günther Bernhardt, Max KellerChemmedchem|August 13, 2009
Bivalent argininamide-type neuropeptide y y(1) antagonists do not support the hypothesis of receptor dimerisationMax Keller, Shangjun Teng, Günther Bernhardt, et al.Archiv Der Pharmazie|April 18, 2015
Toward Labeled Argininamide-Type NPY Y1 Receptor Antagonists: Identification of a Favorable Propionylation Site in BIBO3304Max Keller, Lisa Schindler, Günther Bernhardt, et al.Acta Crystallographica. Section C, Crystal Structure Communications|June 7, 2012
Two dibenzodiazepinone molecules with dissimilar dimeric associations and apparent different tautomeric formsMax Keller, Mohan M Bhadbhade, Roger W ReadACS Pharmacology & Translational Science|March 20, 2025
Characterization of [3H]Propionylated Human Peptide YY-A New Probe for Neuropeptide Y Y2 Receptor Binding StudiesFranziska Schettler, Albert O Gattor, Pierre Koch, et al.Bioorganic & Medicinal Chemistry|October 15, 2008
Modular synthesis of non-peptidic bivalent NPY Y1 receptor antagonistsStefan Weiss, Max Keller, Günther Bernhardt, et al.Journal of Medicinal Chemistry|July 3, 2020
Oligopeptides as Neuropeptide Y Y4 Receptor Ligands: Identification of a High-Affinity Tetrapeptide Agonist and a Hexapeptide AntagonistAdam Konieczny, Diana Braun, David Wifling, et al.RSC Medicinal Chemistry|January 22, 2021
Argininamide-type neuropeptide Y Y1 receptor antagonists: the nature of N ω-carbamoyl substituents determines Y1R binding mode and affinityJonas Buschmann, Theresa Seiler, Günther Bernhardt, et al.Chemmedchem|January 31, 2013
[(3)H]UR-PLN196: a selective nonpeptide radioligand and insurmountable antagonist for the neuropeptide Y Y(2) receptorNikola Pluym, Paul Baumeister, Max Keller, et al.ACS Omega|September 18, 2018
Highly Potent, Stable, and Selective Dimeric Hetarylpropylguanidine-Type Histamine HSteffen Pockes, David Wifling, Max Keller, et al.Pageof 7